Isolation and study of an acquired inhibitor of human coagulation factor V.
about
Inherited disorders of platelet alpha-granules.The factor V light chain mediates the binding and endocytosis of plasma-derived factor V by megakaryocytes.Acquired hemophilia.Rare acquired bleeding disorders.Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.Research approaches for studying flow-induced thromboembolic complications in blood recirculating devices.Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.Acquired factor V inhibitors: a systematic review.Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review.Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.A unique function for LRP-1: a component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes.Severe postoperative hemorrhage caused by antibody-mediated coagulation factor deficiencies: report of two cases.High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia.Laparoscopic surgery in a woman with factor V deficiency: revisiting platelet factor V.Acquired factor V deficiency and mini literature review.Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granulesCoagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes.
P2860
Q33371665-1C0BD0C2-DCD2-4204-8F23-7D6856EBD4B6Q33711510-E67DABF7-B3CF-495A-BE7B-E5214501F195Q34530406-D8CD315B-4694-4701-AA5E-88BE7729A048Q34530416-E0DC1F96-368C-4663-ADB0-9FC42DD52445Q34564920-928F64B8-4E96-4404-A46F-A2386539829CQ35613332-18FA1D05-B07A-46BC-9B69-33CA7740308AQ35692419-BD7595EA-48EA-425F-97A9-ED1334137CDAQ36314915-2D33BA8A-892A-4D63-A22B-58E438BBB6A0Q36713533-1372CF06-EA88-495B-AB0A-290FA83ECDE1Q36717080-9C9963D4-DA1B-4EA8-A6A7-F17D3E6A46A3Q37100189-D599DB8F-8BEE-49C0-AFAC-03335879B875Q37492672-BD41B477-AF65-4807-9773-D325A40114E5Q37807275-75B3CDE5-23BA-45AC-ACC5-B53808F88668Q38113558-9C81DCF9-E1DF-417C-B633-5BEE84EC3DBDQ38490543-F80DF066-AFA8-4D8F-A6D0-B5751C8CB6EAQ40025300-914000D8-6438-41D6-8317-1C180D7A2C02Q44068127-66DF47B2-6133-44E5-AAB9-54A5C39FED85Q44131632-0FCA7722-36EB-4ADF-8C8B-495623B0A939Q44640434-2C6C3204-93C5-4F98-A034-CF22C79E17D7Q45855511-2617DE37-3AFC-44AF-9E7D-95AA89F794E3Q45856617-9BF7028C-8F48-4ACD-A6E4-F99EBA5E9168Q45856641-148F9AD7-B658-4EEE-BC8E-E5311B2DA121Q45873205-CD9EA7D6-843A-4754-88B7-1490F5056140Q52162420-EFADFF39-3F1F-4BAF-BBBE-E88B236267F4Q53033474-21BC3B12-C786-4FE8-AB59-75ACF7292762Q53573313-CF0FA4C9-D93A-4AE4-A202-B072D2FC3DD2
P2860
Isolation and study of an acquired inhibitor of human coagulation factor V.
description
1986 nî lūn-bûn
@nan
1986 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Isolation and study of an acquired inhibitor of human coagulation factor V.
@ast
Isolation and study of an acquired inhibitor of human coagulation factor V.
@en
Isolation and study of an acquired inhibitor of human coagulation factor V.
@nl
type
label
Isolation and study of an acquired inhibitor of human coagulation factor V.
@ast
Isolation and study of an acquired inhibitor of human coagulation factor V.
@en
Isolation and study of an acquired inhibitor of human coagulation factor V.
@nl
prefLabel
Isolation and study of an acquired inhibitor of human coagulation factor V.
@ast
Isolation and study of an acquired inhibitor of human coagulation factor V.
@en
Isolation and study of an acquired inhibitor of human coagulation factor V.
@nl
P2093
P2860
P356
P1476
Isolation and study of an acquired inhibitor of human coagulation factor V.
@en
P2093
J G Houston
M E Nesheim
R B Schenk
W L Nichols
P2860
P304
P356
10.1172/JCI112318
P407
P577
1986-02-01T00:00:00Z